Clinical Study
The Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population
Table 1
Characteristics of all T2DM, patients with HH, primary hypogonadism (PH), and with normal testosterone concentration (normal TT/cfT) and nondiabetic control men.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shows differences between patients with HH and with normal testosterone levels. shows differences between TD2M and nonobese control group. Pearson coefficient of BMI and TT: in all T2DM group. Pearson coefficient of BMI and cfT: in all T2DM group. Pearson coefficient of BMI and E2: in all T2DM group. Pearson coefficient of HbA1c and TT: in all T2DM group. Pearson coefficient of HbA1c and cfT: in all T2DM group. Pearson coefficient of HbA1c and E2: in all T2DM group. Pearson coefficient of FPG and TT: in all T2DM group. |